Tesla Q2 2026 10-Q stock analysis: sales up 26%, operating income down
Tesla's 10-Q for the quarter ended June 30, 2026 showed revenue of $28.2 billion, up 26%, while operating income fell to $398 million and credit sales dropped.
Key takeaways
- This stock analysis reviews Tesla’s Form 10-Q for the second quarter of 2026, filed with the SEC on July 23, 2026.
- Total revenue rose about 26% to $28.2 billion from $22.5 billion a year earlier, with growth in all three reported revenue lines.
- Operating income fell to $398 million from $923 million, even as gross profit increased.
- Net income attributable to common stockholders was $1.11 billion, or $0.32 per diluted share, compared with $1.17 billion and $0.33.
- Automotive regulatory credit revenue dropped to $146 million from $439 million.
Stock analysis: revenue grew across the board
Tesla’s second-quarter top line was the strongest part of the filing. Revenue of $28,236 million compared with $22,496 million in the same quarter of 2025, an increase of roughly 25.5%.
| Three months ended June 30 | 2026 | 2025 | Change |
|---|---|---|---|
| Automotive revenue | $20,516M | $16,661M | +23% |
| Energy generation and storage | $3,139M | $2,789M | +13% |
| Services and other | $4,581M | $3,046M | +50% |
| Total revenue | $28,236M | $22,496M | +26% |
| Operating income | $398M | $923M | -57% |
| Diluted EPS | $0.32 | $0.33 | -3% |
Automotive revenue, still the core of the business, rose about 23%. Energy generation and storage grew about 13%. Services and other was the fastest-growing line, up roughly 50% to $4.58 billion.
Margins and operating income
Gross profit rose to $4,751 million from $3,878 million. As a share of revenue, though, gross margin slipped to about 16.8% from about 17.2%. More notably, income from operations fell to $398 million from $923 million, a decline of about 57%. With gross profit higher and operating income lower, the gap points to a sharp increase in operating expenses during the quarter. The summary figures reviewed here do not break out which expense lines drove that increase.
Net income attributable to common stockholders was $1,114 million, down about 5% from $1,172 million. Net income held up far better than operating income, which indicates that items below the operating line, such as interest and other income, contributed meaningfully to the quarter’s bottom line. Diluted earnings per share were $0.32, compared with $0.33.
Regulatory credits shrink
Automotive regulatory credit revenue, which Tesla earns by selling emissions credits to other automakers, fell to $146 million from $439 million. For the first six months, credits totaled $526 million versus $1,034 million a year earlier, roughly half. Because credit sales carry little associated cost, they have historically given an outsized lift to profit, so their decline weighs on margins more than the revenue figures alone suggest.
Six-month view and balance sheet
For the first half of 2026, revenue was $50,623 million, up from $41,831 million. Operating income was $1,339 million versus $1,322 million, and net income attributable to common stockholders was $1,591 million versus $1,581 million. Diluted EPS for the half was $0.45 in both years. That flat result shows how much of the second quarter’s operating decline was offset by a stronger first quarter.
At June 30, 2026, Tesla reported $15,219 million in cash and equivalents and $28,305 million in short-term investments, against total assets of $148,524 million and stockholders’ equity of $86,858 million. Capital expenditures for the first six months were $8,282 million. Combined cash and short-term investments of about $43.5 billion give the company a large cushion relative to that spending pace, which means the decline in operating income does not create an immediate funding concern.
What to watch
The key questions from this filing are whether operating expenses stay at their second-quarter level, whether services revenue continues to grow at a pace well above automotive, and how far regulatory credit revenue falls from here. This review summarizes the filing and does not assess the stock’s valuation or recommend any action.
Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.